Literature DB >> 9199317

Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway.

L F Stancato1, M Sakatsume, M David, P Dent, F Dong, E F Petricoin, J J Krolewski, O Silvennoinen, P Saharinen, J Pierce, C J Marshall, T Sturgill, D S Finbloom, A C Larner.   

Abstract

Activation of early response genes by interferons (IFNs) and other cytokines requires tyrosine phosphorylation of a family of transcription factors termed signal transducers and activators of transcription (Stats). The Janus family of tyrosine kinases (Jak1, Jak2, Jak3, and Tyk2) is required for cytokine-induced tyrosine phosphorylation and dimerization of the Stat proteins. In order for IFNs to stimulate maximal expression of Stat1alpha-regulated genes, phosphorylation of a serine residue in the carboxy terminus by mitogen-activated protein kinase (MAPK) is also required. In HeLa cells, both IFN-beta and oncostatin M (OSM) stimulated MAPK and Raf-1 enzyme activity, in addition to Stat1 and Stat3 tyrosine phosphorylation. OSM stimulation of Raf-1 correlated with GTP loading of Ras, whereas IFN-beta activation of Raf-1 was Ras independent. IFN-beta- and OSM-induced Raf-1 activity could be coimmunoprecipitated with either Jak1 or Tyk2. Furthermore, HeLa cells lacking Jak1 displayed no activation of STAT1alpha, STAT3, and Raf-1 by IFN-beta or OSM and also demonstrated no increase in the relative level of GTP-bound p21ras in response to OSM. The requirement for Jak1 for IFN-beta- and OSM-induced activation of Raf-1 was also seen in Jak1-deficient U4A fibrosarcoma cells. Interestingly, basal MAPK, but not Raf-1, activity was constitutively enhanced in Jak1-deficient HeLa cells. Transient expression of Jak1 in both Jak-deficient HeLa cells and U4A cells reconstituted the ability of IFN-beta and OSM to activate Raf-1 and decreased the basal activity of MAPK, while expression of a kinase-inactive form of the protein showed no effect. Moreover, U4A cells selected for stable expression of Jak1, or COS cells transiently expressing Jak1 or Tyk2 but not Jak3, exhibited enhanced Raf-1 activity. Therefore, it appears that Jak1 is required for Raf-1 activation by both IFN-beta and OSM. These results provide evidence for a link between the Jaks and the Raf/MAPK signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199317      PMCID: PMC232235          DOI: 10.1128/MCB.17.7.3833

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  32 in total

Review 1.  Protein tyrosine phosphorylation as a mechanism which regulates cytokine activation of early response genes.

Authors:  A C Larner; D S Finbloom
Journal:  Biochim Biophys Acta       Date:  1995-05-12

2.  Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation.

Authors:  Z Wen; Z Zhong; J E Darnell
Journal:  Cell       Date:  1995-07-28       Impact factor: 41.582

3.  Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro.

Authors:  P Dent; D B Reardon; D K Morrison; T W Sturgill
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

4.  The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction.

Authors:  M Müller; J Briscoe; C Laxton; D Guschin; A Ziemiecki; O Silvennoinen; A G Harpur; G Barbieri; B A Witthuhn; C Schindler
Journal:  Nature       Date:  1993-11-11       Impact factor: 49.962

5.  Mutant cell lines unresponsive to alpha/beta and gamma interferon are defective in tyrosine phosphorylation of ISGF-3 alpha components.

Authors:  J E Loh; C Schindler; A Ziemiecki; A G Harpur; A F Wilks; R A Flavell
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

6.  Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein.

Authors:  C L Yu; D J Meyer; G S Campbell; A C Larner; C Carter-Su; J Schwartz; R Jove
Journal:  Science       Date:  1995-07-07       Impact factor: 47.728

7.  Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway.

Authors:  S Akira; Y Nishio; M Inoue; X J Wang; S Wei; T Matsusaka; K Yoshida; T Sudo; M Naruto; T Kishimoto
Journal:  Cell       Date:  1994-04-08       Impact factor: 41.582

8.  Ras-dependent and -independent pathways target the mitogen-activated protein kinase network in macrophages.

Authors:  D Büscher; R A Hipskind; S Krautwald; T Reimann; M Baccarini
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

9.  A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6.

Authors:  D Guschin; N Rogers; J Briscoe; B Witthuhn; D Watling; F Horn; S Pellegrini; K Yasukawa; P Heinrich; G R Stark
Journal:  EMBO J       Date:  1995-04-03       Impact factor: 11.598

10.  Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation.

Authors:  R Marais; Y Light; H F Paterson; C J Marshall
Journal:  EMBO J       Date:  1995-07-03       Impact factor: 11.598

View more
  12 in total

Review 1.  Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.

Authors:  W Kolch
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

Review 2.  The interferon signaling network and transcription factor C/EBP-beta.

Authors:  Hui Li; Padmaja Gade; Weihua Xiao; Dhan V Kalvakolanu
Journal:  Cell Mol Immunol       Date:  2007-12       Impact factor: 11.530

Review 3.  The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease.

Authors:  Kathryn L Pothoven; Robert P Schleimer
Journal:  Tissue Barriers       Date:  2017-06-13

4.  JAK2 activates TFII-I and regulates its interaction with extracellular signal-regulated kinase.

Authors:  D W Kim; B H Cochran
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

5.  Tyrosine phosphorylation of the proto-oncoprotein Raf-1 is regulated by Raf-1 itself and the phosphatase Cdc25A.

Authors:  K Xia; R S Lee; R P Narsimhan; N K Mukhopadhyay; B G Neel; T M Roberts
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

6.  Intestinal Na+-K+-ATPase activity and molecular events downstream of interferon-gamma receptor stimulation.

Authors:  Fernando Magro; Sónia Fraga; Tomé Ribeiro; Patrício Soares-da-Silva
Journal:  Br J Pharmacol       Date:  2004-07-26       Impact factor: 8.739

7.  Distinct evolution process among type I interferon in mammals.

Authors:  Lei Xu; Limin Yang; Wenjun Liu
Journal:  Protein Cell       Date:  2013-04-30       Impact factor: 14.870

8.  Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases.

Authors:  Zhangle Zhou; Ole J Hamming; Nina Ank; Søren R Paludan; Anders L Nielsen; Rune Hartmann
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

9.  Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism.

Authors:  F Romerio; A Riva; D Zella
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

10.  PML-II regulates ERK and AKT signal activation and IFNα-induced cell death.

Authors:  Xueqiong Meng; Yixiang Chen; Salvador Macip; Keith Leppard
Journal:  Cell Commun Signal       Date:  2021-07-02       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.